One Unified Platform
EMAW’s platform consolidates multiple trial components, offering one streamlined application for all devices and operating systems. This removes the need for additional apps, devices, and integrations.
Why EMAW is Different
Redefining
eCOA
for Modern Clinical Trials
Modern trials need modern tools. EMAW delivers scientific precision, operational speed, and unified technology where legacy platforms fall short.
Founded in 2018
The Turning Point: Pre-COVID Innovation
EMAW began with a mission to revolutionize real-world data collection through Ecological Momentary Assessments (EMAs) and wearable/sensor technologies. Early on, we recognized the power of remote, patient-centric insights to transform clinical research.
Just before the pandemic, sponsor partners challenged us to expand beyond EMAs—asking for a seamless way to capture eCOA (electronic Clinical Outcome Assessments) and digital biomarkers alongside wearable data. Thanks to our agile, purpose-built architecture, adding these capabilities was technologically simple and highly scalable. This flexibility allowed us to deliver a cost-effective, unified solution at a time when the industry needed it most.
Sponsor-Recognized Value
Trusted by Sponsors. Designed for the Future.
Sponsor partners consistently point to EMAW’s meaningful advantage in the market. While larger, private equity–backed eCOA vendors often deliver expensive, slow, and fragmented solutions, EMAW offers a faster, more affordable alternative—especially for smaller sponsors and early-phase trials.
Our founders are not just technologists—they are practicing scientists. Through deep involvement in clinical studies, they’ve co-authored multiple posters and peer-reviewed papers with trial sponsors. More publications are on the way as large-scale studies wrap up.
Our founders are not just technologists—they are practicing scientists. Through deep involvement in clinical studies, they’ve co-authored multiple posters and peer-reviewed papers with trial sponsors. More publications are on the way as large-scale studies wrap up.
Why Legacy eCOA Falls Short
Legacy Systems Can’t Keep Up
Sponsors often express frustration with traditional eCOA providers. These outdated platforms are cobbled together from multiple, poorly integrated systems, creating unnecessary complexity and cost. The result? Slower trials, more errors, and greater risk.
Require multiple devices and apps
Legacy platforms often rely on separate apps for patients, clinicians, and admins. This leads to confusion, device overload, and added burden for sites and users.Fragmented and siloed data flows
With disconnected systems, data gets routed through multiple channels, increasing the chance of loss, inconsistency, and integration issues later on.Sluggish system performance
Old technology stacks are slower, harder to scale, and frequently can’t keep up with modern trial complexity or hybrid study demands.High maintenance and hidden costs
More devices and systems mean more IT headaches. Sponsors end up paying for constant support, patches, and integrations.Manual data merging increases error risk
Sponsors often have to manually consolidate data from different sources. This creates delays and opens the door for critical data errors.Longer timelines for analysis and submission
Fragmented data means extended cleaning and verification times—delaying insights, compliance, and trial completion.
Our Differentiation
What Sets EMAW Apart?
At EMAW, we are committed to providing a unique, integrated eCOA solution that delivers superior results for sponsors and researchers. Here's how we stand apart from other platforms in the market:
Speed and Agility
EMAW’s platform consolidates multiple trial components, offering one streamlined application for all devices and operating systems. This removes the need for additional apps, devices, and integrations.
Cost-Effective
EMAW’s platform consolidates multiple trial components, offering one streamlined application for all devices and operating systems. This removes the need for additional apps, devices, and integrations.
Patient/Site-Centric Design
Our platform is designed for ease of use by both patients and trial sites. The single device, downloadable application simplifies the experience, reducing the need for multiple devices and minimizing user fatigue.
We Focus on Data
A Singular System for Streamlined Data Flow
Reduces Data Errors
Centralized system minimizes risk of errors by consolidating all data into one location.
Faster Insights for Real-Time Visualization
Real-time data visualization enables quick insights for immediate decision-making.
Facilitates End of Trial Data Analysis
No need for data reorganization or re-entry, ensuring faster analysis at trial completion.
Automated Alerts for Compliance
Real-time flags and alerts ensure higher compliance throughout the trial.
Simple Storage Architecture for Data Science
Efficient data storage enables easy retrieval and deeper analytics.
Drives Better Outcomes and Quality
Consistent data leads to more informed decisions, improving trial outcomes.
Enables Smaller, Faster Trials
Streamlined data management reduces resource requirements, enabling smaller, faster trials.
Better Quality Control for Interim and Final Reporting
Accurate data ensures high-quality control during interim and final reporting stages.